Effects of some antitumor agents on growth and glycolytic enzymes of the flagellate Crithidia.
Some antitumor agents known to specifically inhibit certain tumor cell enzymes were examined for activity against glycolytic enzymes and growth of the insect trypanosomatid, Crithidia fasciculata. The cytoplasmic enzymes hexokinase, alpha-glycerophosphate dehydrogenase, malic dehydrogenase, and glucose-6-phosphate dehydrogenase were tested. Agaricic acid (2-hydroxy-1,2,3-nonadecane tricarboxylic acid) was highly inhibitory (50 to 100%) to malic and alpha-glycerophosphate dehydrogenases at approximately 3 x 10(-5)m; 2-(p-hydroxyphenyl)-2-phenylpropane (2 x 10(-4)m), and 5,6-dichloro-2-benzoxazolinone (5 x 10(-4)m) were less effective (50% inhibition) against them. The antiprotozoal agents primaquine (4 x 10(-4)m) and Melarsoprol (8 x 10(-4)m) were 30 to 40% inhibitory. Agaricic acid, 2-(p-hydroxyphenyl)-2-phenylpropane, and 5,6-dichloro-2-benzoxazolinone inhibited growth of Crithidia at less than 10(-4)m. Eight other test compounds from the Cancer Chemotherapy National Service Center (CCNSC) were not toxic to cell growth, although two (4-biphenylcarboxylic acid and 1-[p-chlorobenzyl]-2-ethyl-5-methyl-indole-3-acetic acid) inhibited Crithidia alpha-glycerophosphate dehydrogenase below 1 mm. All of the compounds used specifically inhibited cancer cell alpha-glycerophosphate dehydrogenase. The corresponding enzyme in pathogenic African trypanosomes is important in their terminal respiration. C. fasciculata may be useful in preliminary evaluation of chemotherapeutic agents as potential trypanocides.
D000085:Acetates / Q000494:pharmacology; D000143:Acids / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D001152:Arsenicals / Q000494:pharmacology; D001583:Benzoxazoles / Q000494:pharmacology; D056890:Eukaryota / Q000187:drug effects*; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors*; D005993:Glycerolphosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006593:Hexokinase / Q000037:antagonists & inhibitors; D006801:Humans; D008291:Malate Dehydrogenase / Q000037:antagonists & inhibitors; D009369:Neoplasms / Q000201:enzymology; D011319:Primaquine / Q000494:pharmacology; D014345:Trypanosoma / Q000201:enzymology; D014353:Trypanosomiasis, African / Q000188:drug therapy
D000085:Acetates; D000143:Acids; D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D001152:Arsenicals; D001583:Benzoxazoles; D005993:Glycerolphosphate Dehydrogenase; D008291:Malate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D006593:Hexokinase; D011319:Primaquine